Public map story

Michelle Yeoh · Kind Beacon

On the public-interest radar: News pulse 2026-08-19 · France 24: Merck and Moderna report that their cancer vaccine candidate showed positive results in their late-stage trial in preventing a recurrence of melanoma, including in high-risk patients. A perspective from Prague.

event · Kyiv, UA · 0 likes · 1 replies